IL6 and osteonecrosis: Instead, we show that osteonecrosis development in infectious osteomyelitis mice administered alendronate was significantly blocked by gene targeting of either TNFα-, IL-6 or IL-1α/β, or by treatment with a TNFα inhibitor.